期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
中西医结合治疗急性冠脉综合征临床观察 被引量:1
1
作者 王敏 梁梦 朱圣文 《新中医》 CAS 2015年第7期26-28,共3页
目的:观察中西医结合治疗急性冠脉综合征(ACS)的临床疗效。方法:随机双盲法将100例患者分为对照组与观察组,各50例,对照组患者采取常规西医治疗,观察组患者则行中西医结合治疗,比较2组临床疗效、治疗前后中医症状积分、心功能指标及不... 目的:观察中西医结合治疗急性冠脉综合征(ACS)的临床疗效。方法:随机双盲法将100例患者分为对照组与观察组,各50例,对照组患者采取常规西医治疗,观察组患者则行中西医结合治疗,比较2组临床疗效、治疗前后中医症状积分、心功能指标及不良事件发生情况。结果:观察组总有效率96.0%,与对照组的80.0%比较,差异有统计学意义(P<0.05)。2组治疗后心悸、气短、胸闷及胸痛症状积分较治疗前明显下降(P<0.05);且观察组治疗后气短、胸闷及胸痛症状积分明显低于对照组(P<0.05)。2组治疗后左室射血分数(LVEF)、舒张早期值流速(EPFV)、舒张晚期峰值流速(APEV)、心输出量(CO)较治疗前明显改善,差异有统计学意义(P<0.05);观察组治疗后LVEF、CO明显优于对照组(P<0.05)。观察组发生不良心血管事件3例(6.0%),心肌缺血、心肌梗死复发、死亡各1例;对照组发生不良心血管事件11例(22.0%),死亡、心肌梗死各3例,心肌缺血5例。2组不良心血管事件发生率比较,差异有统计学意义(P<0.05)。结论:中西医结合治疗能明显改善患者临床症状及心功能,降低不良心血管事件发生率,可作为ACS治疗的重要手段。 展开更多
关键词 急性冠脉综合征(ACS) 中西医结合疗法 左室射血分数(LVEF) 舒张早期值流速(EPFV) 舒张晚期峰值流速(apev) 心输出量(CO)
下载PDF
Innovation Capability and Export Performance of Turkish Export Firms
2
作者 Kumru Uyar Burcu Oralhan 《Chinese Business Review》 2017年第10期481-495,共15页
In today's competitive environment the key element is the differentiation of business which will lead to success. Especially in international markets where there's much more intense competition, it is more important... In today's competitive environment the key element is the differentiation of business which will lead to success. Especially in international markets where there's much more intense competition, it is more important for businesses to enter with innovations that make a difference to their consumers. Innovation is also important for competitive export-oriented production in globalization. In global competition, innovation is the key factor for sustainable success. Increases in the efficiency, profitability of firms make it possible to enter new markets and extend present markets by obtaining advantage of competition. In order to determine accurate strategies, the connection between innovation and exports must be understood better. The aim of this study is to determine the innovation capability and export performance of Turkish export firms. Another aim is to examine the relationship between firm characteristics and innovation capability. Innovation capability of export firms is measured by INNOVSCALE which was developed by Vicente, Abrantes, and Teixeira (2015). Export performance is measured by APEV scale which was developed by Lages, Lages, and Lages (2005). The study uses data collected from 83 firms located in Kayseri. Results obtained by using SPSS indicate that there is a positive relationship between innovation capability and export performance. The results of the ANOVA analysis, innovation capability differ in terms of firm size and export earnings. Innovation capability does not differ in terms of sector, operating years, share of export earnings in the whole revenues, exporting periods, or internationalization levels. 展开更多
关键词 INNOVATION export performance INNOVSCALE apev scale intemational trade TURKEY
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部